期刊文献+

Wingspan支架治疗症状性颅内动脉狭窄90例临床疗效分析 被引量:5

Tretment of symptomatic intracranial artery stenosis with Wingspan stents system
下载PDF
导出
摘要 目的探讨Wingspan支架治疗症状性颅内动脉狭窄的安全性、可行性和并发症。方法应用Wingspan支架治疗90例(92个部位)症状性颅内动脉狭窄患者,观察其症状改善、狭窄率及严重不良事件的发生率。术后行脑血管造影术或CTA血管成像观察支架内再狭窄发生率。结果患者术前平均狭窄率为(83.4±9.5)%,Wingspan支架置入后平均残余狭窄率为(21.8±9.8)%。临床随访1~40个月,平均(16.7±10.3)个月,围手术期总并发症发生率为6.5%(6/92),30d内任何脑卒中和31d~1年内同侧缺血性卒中的发生率为10.9%。30例患者接受了血管造影复查,6个月再狭窄率为10.0%(3/30)。结论 Wingspan支架治疗症状性颅内动脉狭窄具有较好的安全性和临床疗效,围手术期总的并发症发生率较低。 Objective To investigate the safety,feasibility and complications of the Wingspan stent in treatment of symptomatic intracranial arterial stenosis. Methods Treatment with Wingspan stents was attempted in 90 ( 92 Lesions ) patients with symptomatic intracranial artery stenosis. The clinical outeome,stenosis improvement and major complications were abserved. Conventional cerebral angiography or CTA was performed after stenting. Rsults The average degree of stenosis before stenting preeedure was(83.4 ± 9.5)%,the residual stenosis degree after stenting was(21.8 ± 9.8)%. The frequency of any stroke within 30 days or ipsilateral ischemic stroke between 30 days and 12 months was 10.9% during a mean follow-up time of (16.7 ±10:3)months ( ranged between 1-40 months ) .Cerebral angiography check-up was conducted in 30 eases.The frequency of restenosis was 10.0%(3/30)at 6 months. Conclusion Symptomatic intraeranial artery stenosis can be treated with Wingspan stent with acceptable safety and clinic outcome. The overall perioperative complications is low.
出处 《中国医药科学》 2012年第8期186-187,189,共3页 China Medicine And Pharmacy
关键词 颅内动脉狭窄 支架 并发症 Intracranial arterial stenosis Stent Complieation
  • 相关文献

参考文献12

  • 1Taylor RA, Kasner SE.Natural History of Asymptomatic Intracranial Arterial Stenosis[J].Neuroimaging, 2009,19 ( 1 ): 17S-19S. 被引量:1
  • 2Chimowitz MI, Lynn MJ, Howlett-Smith H, et al.Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis[J].N Engl J Med, 2005,352 ( 13 ) : 1305-1316. 被引量:1
  • 3Kasner SE, Chimowitz MI, Lynn M J, et al.Predictors of isehemic stroke in the territory of a symptomatic intracranial arterial stenosls[J].Circulation, 2006,113 ( 4 ): 1555-1563. 被引量:1
  • 4Levy EI, Turk AS, Albuquerque FC, et al.Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management[J]. Neurosurgury, 2007,61 ( 3 ) : 644-651. 被引量:1
  • 5Bose A, Hartmann M, Henkes H, et al.A novel, selfexpanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study[J]. Stroke,2007,38 ( 5 ): 1531-1537. 被引量:1
  • 6Zaidat 00, Klucznik R, Alexander MJ, et aI.NIH Multi-center Wingspan intraeranial stent registry study group.The NIH registry on use of the Wingspan stent for symptomatic 70%-99% intracranial arterial stenosis[J].Neurology, 2008,70 ( 17): 1518-1524. 被引量:1
  • 7Brus-Ramer M, Starke RM, Komotar RJ, et al.Radiographic evidence of cerebral hyperperfusion and reversal following angioplasty and stenting of intracranial carotid and middle cerebral artery stenosis: case report and review of the literature[J].J Neuroimaging, 2010,20 ( 30 ): 280-283. 被引量:1
  • 8Hosoda K, Kawaguchida T, Shibata Y.Cerebral vasoreactivity and internal carotid artery flow help to identify patients at risk for heperperfution after carotid endartereetomy[J].Stroke, 2001,32 ( 7 ) : 1567-1573. 被引量:1
  • 9Terada T, Tsuura M, Matsumoto H.Hemerrhagic complications after endovacular therapy for atherosclerotic intracranial arterialstenoses[J]. Neurosurgery,2006,59 (2): 310-318. 被引量:1
  • 10i Wolf TJ, Fitzsimmons BF, Hussain SI, et al.Long term clinical and angiographic outcomes with the Wingspan stent for treatment of symptomatic 50%-90% intracranial Atherosclerosis: single center experience in 51.cases[J].Neurointerv Serg, 2009,1 ( 1 ) : 40-43. 被引量:1

同被引文献65

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部